CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2021; 42(02): 190-193
DOI: 10.1055/s-0041-1731843
Policy Brief

Vaccination Against Cervical Cancer in India: Our Children Deserve a Healthier Future

1  Department of Medical and Pediatric Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India
Catherine G Lam
2  Director of Health Systems and Asia Pacific Regional Programs, St. Jude Children’s Research Hospital, Memphis, TN, USA.
Scott C Howard
3  Professor and Associate Dean for Research in the College of Nursing University of Tennessee College of Health Sciences, Memphis, TN, USA
› Author Affiliations

Executive Summary

  • Cancer of the uterine cervix is the second most common cancer after breast cancer among Indian women.

  • About 604,127 women get this disease every year in the world and 56% of them die.

  • One woman in India dies every 8 minutes from cervical cancer.

  • It mainly affects young women belonging to the lower socioeconomic strata in the productive years of their lives (21–67 years of age).

  • The human papilloma virus (HPV) is responsible for the majority of cervical cancers and an effective vaccine is available against HPV.

  • Vaccination is most effective when given to young girls between the ages of 9 to 13 years before they become sexually active.

  • There is adequate evidence in the literature on the cost-effectiveness of HPV vaccination in preventing cervical cancer.

Publication History

Publication Date:
06 July 2021 (online)

© 2021. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India